Human IgA Isotype Control
Quick Overview for Human IgA Isotype Control (ABIN5633212)
Target
Application
Isotype
-
-
Host
- Human
-
Supplier Product No.
- 009-0106-0001
-
Supplier
- Rockland
-
Purpose
- Human IgA Whole Molecule
-
Cross-Reactivity (Details)
- Human IgA whole molecule was assayed by immunoelectrophoresis resulted in a single precipitin arc against anti-Human Serum and anti-Human IgA (a chain specific). No reaction was observed against anti-Human IgG F(c). Some light chain cross reactivity will occur with anti-Human IgG.
-
Characteristics
- Human Immunoglobulin A
-
Purification
- Human IgA whole molecule was prepared from human serum by a multi-step process which includes delipidation, selective precipitation and tandem molecular sieve chromatography followed by extensive dialysis against the buffer stated above.
-
Sterility
- Sterile filtered
-
-
-
-
Application Notes
-
Immunohistochemistry Dilution: User Optimized
Application Note: Human IgA whole molecule has been tested in SDS-Page and Western blot and can be utilized as a control or standard reagent in SDS, Western Blotting and ELISA experiments.
Western Blot Dilution: User Optimized
ELISA Dilution: User Optimized
Other: User Optimized
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.0 mg/mL
-
Buffer
-
Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Stabilizer: None
Preservative: 0.01 % (w/v) Sodium Azide -
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store vial at 4° C prior to opening. This product is stable 4° C as an undiluted liquid. Dilute only prior to immediate use. For extended storage mix with an equal volume of glycerol, aliquot contents and freeze at -20° C or below. Avoid cycles of freezing and thawing.
-
Expiry Date
- 12 months
-
-
- IgA
-
Target Type
- Antibody
-
Background
- Background: Immunoglobulin A is the primary responder in muscosal immunity, and comprises close to 75 % of the total immunoglobulin produced. IgA can also be secreted and is protected from degradation by many proteolytic enzymes (which allows it to be secreted along the gastrointestinal tract). Immunoglobulin A only weakly activates the complement system and is not readily opsonized.
Target
-